Cytotoxic effects of pyrrolidine dithiocarbamate in small-cell lung cancer cells, alone and in combination with cisplatin

Tahata,Shinichi; Yuan,Bo; Kikuchi,Hidetomo; Takagi,Norio; Hirano,Toshihiko; Toyoda,Hiroo

doi:10.3892/ijo.2014.2564

Cytotoxic effects of pyrrolidine dithiocarbamate in small-cell lung cancer cells, alone and in combination with cisplatin

Authors:
- Shinichi Tahata
- Bo Yuan
- Hidetomo Kikuchi
- Norio Takagi
- Toshihiko Hirano
- Hiroo Toyoda
View Affiliations

Affiliations: Department of Clinical Molecular Genetics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan, Department of Applied Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan, Department of Clinical Pharmacology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan
Published online on: July 28, 2014 https://doi.org/10.3892/ijo.2014.2564
Pages: 1749-1759

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The cytocidal effect of pyrrolidine dithiocarbamate (PDTC) was investigated by focusing on cell viability, cell cycle arrest and apoptosis induction in small-cell lung cancer (SCLC) cell lines (NCI-H196 and NCI-H889). PDTC exhibited a much stronger dose-dependent cytotoxic activity against NCI-H196 compared to NCI-H889, while no such activity was observed in normal human embryonal lung fibroblast MRC-5 cells. Cell cycle arrest in S phase paralleled with suppression of c-myc expression without accompanying DNA fragmentation was observed in NCI-H196 cells. A transient increase in the intracellular ROS accompanied with an alteration of expression of oxidative stress-related genes was also confirmed in NCI-H196 cells. Furthermore, the addition of N-acetyl-l-cysteine (NAC), a free radical scavenger, not only abolished PDTC-trigger alterations of expression of these oxidative-related genes, but also almost completely abrogated PDTC-induced reduction in cell viability and morphological changes associated with cell damage. These results thus suggest that PDTC-induced cytotoxicity is attributed to its pro-oxidant activity. PDTC-induced cytotoxicity was further enhanced by CuCl2, however, abolished by bathocuproine disulfonate (BCPS), a non-permeable copper-specific chelator, supporting the plausibility that accumulation of intracellular Cu plays an important role in the cytotoxicity. Importantly, we demonstrated for the first time that PDTC downregulated the expression of ATP7A, known to be responsible for Cu efflux, but did not affect the expression of CTR1, known as a copper uptake transporter. Intriguingly, combination of much lower dose of cisplatin (5 µM) and non-toxic dose of PDTC (0.1 µM) synergistically induced a significant cytotoxicity in NCI-H196 cells. Given that ATP7A plays a critical role in the resistance of platinum-drug (such as cisplatin) representing a first-line treatment for SCLC, PDTC could be a promising candidate of adjunct therapeutic reagent for the patients requiring treatment with platinum-based regimens.

View Figures

View References

1	Chan BA and Coward JI: Chemotherapy advances in small-cell lung cancer. J Thorac Dis. 5:S565–S578. 2013.PubMed/NCBI
2	van Meerbeeck JP, Fennell DA and De Ruysscher DK: Small-cell lung cancer. Lancet. 378:1741–1755. 2011.
3	Jackman DM and Johnson BE: Small-cell lung cancer. Lancet. 366:1385–1396. 2005. View Article : Google Scholar : PubMed/NCBI
4	Chinery R, Brockman JA, Peeler MO, Shyr Y, Beauchamp RD and Coffey RJ: Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21^WAF1/CIP1 via C/EBPbeta. Nat Med. 3:1233–1241. 1997. View Article : Google Scholar : PubMed/NCBI
5	Herrmann JL, Beham AW, Sarkiss M, et al: Bcl-2 suppresses apoptosis resulting from disruption of the NF-kappa B survival pathway. Exp Cell Res. 237:101–109. 1997. View Article : Google Scholar : PubMed/NCBI
6	Chen SH, Liu SH, Liang YC, Lin JK and Lin-Shiau SY: Death signaling pathway induced by pyrrolidine dithiocarbamate-Cu(2+) complex in the cultured rat cortical astrocytes. Glia. 31:249–261. 2000. View Article : Google Scholar : PubMed/NCBI
7	Forman HJ, York JL and Fisher AB: Mechanism for the potentiation of oxygen toxicity by disulfiram. J Pharmacol Exp Ther. 212:452–455. 1980.PubMed/NCBI
8	Goldstein BD, Rozen MG, Quintavalla JC and Amoruso MA: Decrease in mouse lung and liver glutathione peroxidase activity and potentiation of the lethal effects of ozone and paraquat by the superoxide dismutase inhibitor diethyldithiocarbamate. Biochem Pharmacol. 28:27–30. 1979. View Article : Google Scholar
9	Nobel CI, Kimland M, Lind B, Orrenius S and Slater AF: Dithiocarbamates induce apoptosis in thymocytes by raising the intracellular level of redox-active copper. J Biol Chem. 270:26202–26208. 1995. View Article : Google Scholar
10	Donadelli M, Dalla Pozza E, Costanzo C, et al: Increased stability of P21(WAF1/CIP1) mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidine dithiocarbamate. Biochim Biophys Acta. 1763:917–926. 2006. View Article : Google Scholar : PubMed/NCBI
11	Chen SH, Lin JK, Liang YC, Pan MH, Liu SH and Lin-Shiau SY: Involvement of activating transcription factors JNK, NF-kappaB, and AP-1 in apoptosis induced by pyrrolidine dithiocarbamate/Cu complex. Eur J Pharmacol. 594:9–17. 2008. View Article : Google Scholar : PubMed/NCBI
12	Morais C, Gobe G, Johnson DW and Healy H: Inhibition of nuclear factor kappa B transcription activity drives a synergistic effect of pyrrolidine dithiocarbamate and cisplatin for treatment of renal cell carcinoma. Apoptosis. 15:412–425. 2010. View Article : Google Scholar
13	Venkatraman M, Anto RJ, Nair A, Varghese M and Karunagaran D: Biological and chemical inhibitors of NF-kappaB sensitize SiHa cells to cisplatin-induced apoptosis. Mol Carcinog. 44:51–59. 2005. View Article : Google Scholar : PubMed/NCBI
14	Evans WK, Shepherd FA, Feld R, Osoba D, Dang P and Deboer G: VP-16 and cisplatin as first-line therapy for small-cell lung cancer. J Clin Oncol. 3:1471–1477. 1985.PubMed/NCBI
15	Sundstrom S, Bremnes RM, Kaasa S, et al: Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years’ follow-up. J Clin Oncol. 20:4665–4672. 2002.PubMed/NCBI
16	Safaei R: Role of copper transporters in the uptake and efflux of platinum containing drugs. Cancer Lett. 234:34–39. 2006. View Article : Google Scholar : PubMed/NCBI
17	Samimi G, Safaei R, Katano K, et al: Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin Cancer Res. 10:4661–4669. 2004. View Article : Google Scholar : PubMed/NCBI
18	Safaei R, Katano K, Samimi G, et al: Cross-resistance to cisplatin in cells with acquired resistance to copper. Cancer Chemother Pharmacol. 53:239–246. 2004. View Article : Google Scholar : PubMed/NCBI
19	Inoue Y, Matsumoto H, Yamada S, et al: Association of ATP7A expression and in vitro sensitivity to cisplatin in non-small cell lung cancer. Oncol Lett. 1:837–840. 2010.
20	Li ZH, Qiu MZ, Zeng ZL, et al: Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC). J Transl Med. 10:212012. View Article : Google Scholar : PubMed/NCBI
21	Song L, Li Y, Li W, Wu S and Li Z: miR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A). J Cell Biochem. 115:1234–1242. 2014. View Article : Google Scholar : PubMed/NCBI
22	Imai M, Kikuchi H, Denda T, Ohyama K, Hirobe C and Toyoda H: Cytotoxic effects of flavonoids against a human colon cancer derived cell line, COLO 201: a potential natural anticancer substance. Cancer Lett. 276:74–80. 2009. View Article : Google Scholar
23	Yuan B, Ohyama K, Bessho T and Toyoda H: Contribution of inducible nitric oxide synthase and cyclooxygenase-2 to apoptosis induction in smooth chorion trophoblast cells of human fetal membrane tissues. Biochem Biophys Res Commun. 341:822–827. 2006. View Article : Google Scholar
24	Kikuchi H, Yuan B, Yuhara E, Takagi N and Toyoda H: Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60. Int J Oncol. 43:2046–2056. 2013.PubMed/NCBI
25	Kon A, Yuan B, Hanazawa T, et al: Contribution of membrane progesterone receptor alpha to the induction of progesterone-mediated apoptosis associated with mitochondrial membrane disruption and caspase cascade activation in Jurkat cell lines. Oncol Rep. 30:1965–1970. 2013.
26	Hu XM, Yuan B, Tanaka S, et al: Involvement of oxidative stress associated with glutathione depletion and p38 mitogen-activated protein kinase activation in arsenic disulfide-induced differentiation in HL-60 cells. Leuk Lymphoma. 55:392–404. 2014. View Article : Google Scholar
27	Obaya AJ, Mateyak MK and Sedivy JM: Mysterious liaisons: the relationship between c-Myc and the cell cycle. Oncogene. 18:2934–2941. 1999. View Article : Google Scholar : PubMed/NCBI
28	Zhang P, Li H, Wu ML, et al: c-Myc downregulation: a critical molecular event in resveratrol-induced cell cycle arrest and apoptosis of human medulloblastoma cells. J Neurooncol. 80:123–131. 2006. View Article : Google Scholar
29	Payne CM, Bernstein C and Bernstein H: Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways. Leuk Lymphoma. 19:43–93. 1995. View Article : Google Scholar : PubMed/NCBI
30	Keyse SM and Tyrrell RM: Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci USA. 86:99–103. 1989. View Article : Google Scholar : PubMed/NCBI
31	Keyse SM and Tyrrell RM: Both near ultraviolet radiation and the oxidizing agent hydrogen peroxide induce a 32-kDa stress protein in normal human skin fibroblasts. J Biol Chem. 262:14821–14825. 1987.
32	Furuta S, Ortiz F, Zhu Sun X, Wu HH, Mason A and Momand J: Copper uptake is required for pyrrolidine dithiocarbamate-mediated oxidation and protein level increase of p53 in cells. Biochem J. 365:639–648. 2002.PubMed/NCBI
33	Oltersdorf T, Elmore SW, Shoemaker AR, et al: An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 435:677–681. 2005. View Article : Google Scholar : PubMed/NCBI
34	Olejniczak ET, Van Sant C, Anderson MG, et al: Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains. Mol Cancer Res. 5:331–339. 2007. View Article : Google Scholar
35	Malaguarnera L, Pilastro MR, DiMarco R, et al: Cell death in human acute myelogenous leukemic cells induced by pyrrolidinedithiocarbamate. Apoptosis. 8:539–545. 2003. View Article : Google Scholar : PubMed/NCBI
36	Cheng YC, Lin H, Huang MJ, Chow JM, Lin S and Liu HE: Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemia. Leuk Res. 31:1403–1411. 2007. View Article : Google Scholar : PubMed/NCBI
37	Jang M, Cai L, Udeani GO, et al: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:218–220. 1997. View Article : Google Scholar : PubMed/NCBI
38	Aragones J, Lopez-Rodriguez C, Corbi A, et al: Dithiocarbamates trigger differentiation and induction of CD11c gene through AP-1 in the myeloid lineage. J Biol Chem. 271:10924–10931. 1996. View Article : Google Scholar : PubMed/NCBI
39	Bae KM, Wang H, Jiang G, Chen MG, Lu L and Xiao L: Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner. Cancer Res. 67:6053–6063. 2007. View Article : Google Scholar : PubMed/NCBI
40	Lloyd DR and Phillips DH: Oxidative DNA damage mediated by copper(II), iron(II) and nickel(II) fenton reactions: evidence for site-specific mechanisms in the formation of double-strand breaks, 8-hydroxydeoxyguanosine and putative intrastrand cross-links. Mutat Res. 424:23–36. 1999. View Article : Google Scholar
41	Zhang H, Wu JS and Peng F: Potent anticancer activity of pyrrolidine dithiocarbamate-copper complex against cisplatin-resistant neuroblastoma cells. Anticancer Drugs. 19:125–132. 2008. View Article : Google Scholar